机译:Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients
Univ Copenhagen, Rigs hosp, Dept Haematol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark;
Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark;
Vejle Hosp, Dept Haematol, Vejle, DenmarkHerlev Univ Hosp, Dept Haematol, Herlev, DenmarkOdense Univ Hosp, Dept Haematol, Odense, DenmarkOdense Univ Hosp, Dept Pathol, Odense, DenmarkHerlev Univ Hosp, Dept Pathol, Herlev, DenmarkZealand Univ Hosp, Dept Haematol, Roskilde, DenmarkAarhus Univ Hosp, Dept Haematol, Aarhus, DenmarkReg hosp Holstebro, Dept Haematol, Holstebro, DenmarkEsbjerg Cent Hosp, Dept Haematol, Esbjerg, DenmarkRigs hosp, Dept Clin Genet, Copenhagen, DenmarkZealand Univ Hosp, Dept Pathol, Roskilde, Denmark;
carfilzomib; daratumumab; multiple myeloma; real-world evidence;